Novelix Pharma.

{
  "main_header": {
    "sid": 200695,
    "name": "Novelix Pharma.",
    "stock_name": "Novelix Pharma.",
    "full_name": "Novelix Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/novelix-pharma",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "75.80",
    "chg": 2.08,
    "chgp": "2.82%",
    "dir": 1,
    "prev_price": "73.72",
    "mcapval": "200.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 536565,
    "symbol": "",
    "ind_name": "Retailing",
    "ind_code": 4,
    "sector_id": 72,
    "indexname": "India SENSEX",
    "isin": "INE314I01036",
    "curr_date": "Aug 07, 02:16 PM",
    "curr_time": "14:48 PM",
    "last_traded_at": "Aug 07, 02:16 PM IST",
    "bse_nse_vol": "4.5 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/novelix-pharma-200695-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4141713",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/NovelixPharmace_mojoScore_4141713.png",
        "date": "2026-08-07 10:10:03",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4122513",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NovelixPharmace_mojoScore_4122513.png",
        "date": "2026-07-27 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4105058",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NovelixPharmace_mojoScore_4105058.png",
        "date": "2026-07-16 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-valuation-shifts-signal-renewed-price-attractiveness-4095605",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NovelixPharmace_valuationdot_4095605.png",
        "date": "2026-07-10 08:00:11",
        "description": "Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a changing investor sentiment amid mixed market signals. Despite a recent 4.01% dip in its share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more attractive entry point compared to its historical highs and peer group averages."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4089511",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/NovelixPharmace_mojoScore_4089511.png",
        "date": "2026-07-05 10:10:05",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Novelix Pharmaceuticals Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/novelix-pharmaceuticals-ltd-is-rated-hold-4069028",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_mojoScore_4069028.png",
        "date": "2026-06-23 10:10:04",
        "description": "Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Novelix Pharmaceuticals Drops 8.23%: 4 Key Factors Driving the Weekly Decline",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-drops-823-4-key-factors-driving-the-weekly-decline-4066295",
        "imagepath": "",
        "date": "2026-06-21 14:00:06",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Jun:</strong> New 52-week and all-time high at Rs.87.90</p>\n                    <p><strong>16 Jun:</strong> Stock hits new 52-week and all-time high at Rs.92.00</p>\n                    <p><strong>17 Jun:</strong> Sharp decline begins with a 5.42% drop</p>\n                    <p><strong>19 Jun:</strong> Week closes at Rs.75.82, down 8.23%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.82.62</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.75.82</div><div class=\"stat-change negati..."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-hits-new-52-week-high-at-rs92-4055593",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_priceRelatedfactors_4055593.png",
        "date": "2026-06-16 09:42:32",
        "description": "Surging past its previous peaks, Novelix Pharmaceuticals Ltd touched a fresh 52-week high of Rs 92 on 16 Jun 2026, marking a remarkable rally that has seen the stock gain nearly 197% over the past year, vastly outperforming the Sensex’s decline of 6.37% during the same period."
      },
      {
        "title": "From Streak to Summit: Novelix Pharmaceuticals Ltd Hits All-Time High at Rs 92",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/novelix-pharmaceuticals-ltd-stock-hits-all-time-high-at-rs92-4055556",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/NovelixPharmace_priceRelatedfactors_4055556.png",
        "date": "2026-06-16 09:32:10",
        "description": ""
      }
    ],
    "total": 141,
    "sid": "200695",
    "stock_news_url": "https://www.marketsmojo.com/news/novelix-pharmaceuticals-200695"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "16-Jul-2026",
      "details": "Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "13-Jul-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Srinidhi Fine - Chemicals LLP & Others",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 2015",
      "datetime": "13-Jul-2026",
      "details": "Submission of Intimation under regulation 7(2) of SEBI (PIT) Regulations 2015.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has declared <strong>3%</strong> dividend, ex-date: 16 Aug 12",
          "dt": "2012-08-16",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Novelix Pharmaceuticals Ltd has announced <strong>10:1</strong> stock split, ex-date: 04 Oct 10",
          "dt": "2010-10-04",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Novelix Pharmaceuticals Ltd is Rated Hold

2026-08-07 10:10:03

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, a rating that was last updated on 13 February 2026. While this rating change occurred earlier this year, the analysis and financial metrics discussed here reflect the stock's current position as of 07 August 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-07-27 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 27 July 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-07-16 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 16 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-07-10 08:00:11

Novelix Pharmaceuticals Ltd has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade, reflecting a changing investor sentiment amid mixed market signals. Despite a recent 4.01% dip in its share price, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more attractive entry point compared to its historical highs and peer group averages.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-07-05 10:10:05

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Novelix Pharmaceuticals Ltd is Rated Hold

2026-06-23 10:10:04

Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 June 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Novelix Pharmaceuticals Drops 8.23%: 4 Key Factors Driving the Weekly Decline

2026-06-21 14:00:06

Key Events This Week

15 Jun: New 52-week and all-time high at Rs.87.90

16 Jun: Stock hits new 52-week and all-time high at Rs.92.00

17 Jun: Sharp decline begins with a 5.42% drop

19 Jun: Week closes at Rs.75.82, down 8.23%

Week Open

Rs.82.62

Week Close

Rs.75.82

Read full news article

Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 92

2026-06-16 09:42:32

Surging past its previous peaks, Novelix Pharmaceuticals Ltd touched a fresh 52-week high of Rs 92 on 16 Jun 2026, marking a remarkable rally that has seen the stock gain nearly 197% over the past year, vastly outperforming the Sensex’s decline of 6.37% during the same period.

Read full news article

From Streak to Summit: Novelix Pharmaceuticals Ltd Hits All-Time High at Rs 92

2026-06-16 09:32:10

Read full news article

View All News